Copyright 2004 American Medical Association. All Rights Reserved.Applicable FARS/DFARS Restrictions Apply to Government Use.
The development of fibrous tissue in patients with occult choroidalneovascularization (CNV) associated with age-related macular degeneration(AMD) is one of the major determinants of vision loss. Usually this processis slow with the development of disciform scarring that exceeds 50% of thelesion occurring in only 20% of eyes by 12 months.1 Thetypical time course is between 30 and 100 months of follow-up.2 Interestingly,in the absence of subretinal blood or classic CNV, no eyes with occult CNVdeveloped more than 50% disciform scarring in a 9- to 12-month follow-up.3
In the present case, we describe clinicopathologic findings in a patientwith AMD who developed progressive subretinal fibrovascular proliferationassociated with occult CNV.
A 76-year-old man had a 3-month history of vision loss and a visualacuity of 20/60 OD as well as turbid subretinal fluid in that eye (Figure 1A). The fellow eye demonstrated avisual acuity of 20/30 and the retinal examination findings in this eye showeddrusen and pigmentary changes of the retinal pigment epithelium (RPE). Onstereofluorescein angiography, leakage of undetermined origin at the levelof the RPE consistent with a 4-disc area of occult CNV was identified in theright eye (Figure 1B and C). Theright eye underwent a rapid and progressive fibrosis over the ensuing 6 months(Figure 1D-F) with visual acuitydeclining to 20/400. The patient underwent vitrectomy with removal of thesubretinal neovascular fibrotic scar.
Fundus photographs and early andlate frames of the fluorescein angiogram of the patient at baseline (A-C)and at 6 months (D-F).
The surgical specimen measured 4 × 3.5 × 1.2 mm. Microscopicanalysis of the neovascular complex demonstrated a well-demarcated lesionwith a 2-component fibrous scar (Figure 2A). The overall thickness of the lesion was approximately 1200 µmwith the subretinal and intra-Bruch's membrane components measuring 1100 and100 µm, respectively. Fibroblastlike cells were evident throughout theextensive matrix of collagen. Many microvascular channels were prominent inthe region external to the RPE and within the outer subretinal area. The innermostregion of fibrosis was relatively acellular and contained few vascular structures.
A, Hematoxylin-eosin stainingrevealed extensive fibrous tissue internal to Bruch's membrane with fibroblastlikecells evident (arrows). Many small vascular channels were detected (asterisks).The inner layer of Bruch's membrane was intact (small arrowheads). The retinalpigment epithelial (RPE) layer was attenuated with focal disruption and lossof pigment granules into surrounding tissues (large arrowheads). B, The subretinalpigment epithelial (subRPE) tissue was markedly hypercellular confirmed byDAPI staining of the cell nuclei. Scale bar = 50 µm.
DAPI staining for cellular nuclei demonstrated striking hypercellularityin the subRPE component of the scar (Figure2B). Many cells in this area were positive for CD68+,a macrophage marker (Figure 3A).The neovascular structures stained positively for CD34+, a markerfor microvascular endothelium and hematopoetic stem cells (Figure 4A), and for von Willebrand factor (vWF) (Figure 4B), a marker for differentiated endothelial cells. Numerousindividual cells identified as CD34+ cells were also located throughoutthe scar. Within the complex, multiple individual isolated cells were CD34+ but vWF negative, indicating possible immature endothelial cells (Figure 4A and B). Tissue stains for vascularendothelial growth factor (VEGF) and pigment epithelium–derived factorwere negative but strongly positive for platelet-derived growth factor (PDGF)B within neovascular endothelial cells (Figure3B). The VEGF from the subretinal fluid was below the detectablelevels by enyme-linked immunosorbent assay (Quantikine Human VEGF Immunoassay;R&D Systems, Inc, Minneapolis, Minn).
A, Immunoperoxidase staining forCD68+ demonstrates extensive staining (arrows) within the subretinalpigment epithelial (subRPE) and subretinal space. B, Cy3 conjugated fluorescentimmunolabeling (red) for platelet-derived growth factor B exhibiting positivestaining within multiple vascular channels (asterisks) both in the subRPEand subretinal components of the lesion. Scale bar = 50 µm.
Cy3 conjugated fluorescent immunolabeling(red) of CD34+ (Becton Dickinson, San Jose, Calif) (A) and vonWillebrand factor (vWF)–positive (Becton Dickinson) (B) cells foundboth adjacent to vascular structures (asterisks) and as individual cells (arrows)in the both the subretinal pigment epithelial (subRPE) and subretinal componentsof the lesion. Throughout the lesion more cells were CD34+ positive(A) than were vWF positive (B). Scale bar = 50 µm.
This patient demonstrated rapid fibrosis of an occult fibrous neovascularmembrane. The histopathology of the present lesion contained microvascularchannels, a prominent fibrotic response, hypercellularity of the tissue comprisingboth inflammatory and endothelial cells, and expression of PDFG B within vascularchannels.
A hypercellular response was most prominent in that portion of the scaradjacent to the RPE. Part of the cellular responses appeared to be a prominentinflammatory component consisting of CD68+ macrophages. This findingsuggests that these cells may participate in the evolution of fibrous neovascularmembranes and support the inflammatory paradigm of CNV in AMD. The originof vascular elements contributing to the subretinal fibrovascular membranein AMD remains uncertain. In the present case, endothelial cells located withinthe microvascular channels were strongly positive for CD34+ andvWF. Many individual cells isolated within the fibrous matrix of this membranewere CD34+ but vWF negative. In addition, many endothelial markerpositive cells were identified as isolated, individual cells rather than embeddedin a neovascular channel. These findings, in this case, suggest that a cellularrather than a vascular invasion may have played a role in the pathogenesisof the neovascular structures. In addition, while vWF staining is specificto endothelial cells, CD34+ also serves as a marker for hematopoeticstem cells. Recently, work with stem cells has highlighted the capacity ofthese cells to differentiate into vascular elements both in vitro and in vivounder the influence of VEGF and PDGF.4 Whetherthis process occurs in the pathogenesis of CNV remains speculative.
Consistent with a previous report on cytokine production in CNV undergoinginvolution,5 this case exhibited a lackof VEGF expression both by immunohistochemistry and quantitative enzyme-linkedimmunosorbent assay. However, prominent PDGF staining was detected withinthe vascular channels. In summary, this surgically excised fibrovascular membranedemonstrates additional findings that add to our knowledge of the molecularbiology of neovascular AMD.
None of the authors has a proprietary interest in any test or productdescribed within this article.
Corresponding author and reprints: Karl Csaky, MD, PhD, Bldg 10,Room 10N119, NEI/NIH, 9000 Rockville Pike, Bethesda, MD 20895-1857 (e-mail: kcsaky@helix.nih.gov).
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Ophthalmology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.